These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35000022)

  • 1. Prognostic value of
    Li Q; Hu L; Charwudzi A; Zhu W; Meng Y; Zhai Z
    Clin Exp Med; 2023 Feb; 23(1):31-43. PubMed ID: 35000022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of
    Han S; Woo S; Kim YI; Yoon DH; Ryu JS
    Eur Radiol; 2021 Jan; 31(1):152-162. PubMed ID: 32809165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of semi-quantitative parameters of
    Wan B; Zhang S; Wang P; Deng P; Dai W
    Ann Nucl Med; 2023 Mar; 37(3):155-165. PubMed ID: 36528697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Baseline
    Moon SH; Choi WH; Yoo IR; Lee SJ; Paeng JC; Jeong SY; Lee SW; Kim K; Choi JY
    Korean J Radiol; 2018; 19(3):481-488. PubMed ID: 29713226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of SUV
    Diao W; Tian F; Jia Z
    Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Morales-Lozano MI; Rodriguez-Otero P; Sancho L; Nuñez-Cordoba JM; Prieto E; Marcos-Jubilar M; Rosales JJ; Alfonso A; Guillen EF; San-Miguel J; Garcia-Velloso MJ
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorodeoxyglucose-avid focal lesions and extramedullary disease on 18F-FDG PET/computed tomography predict the outcomes of newly diagnosed symptomatic multiple myeloma patients.
    Zhong X; Diao W; Zhao C; Jia Z
    Nucl Med Commun; 2020 Sep; 41(9):950-958. PubMed ID: 32796484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of [
    Stolzenburg A; Lückerath K; Samnick S; Speer M; Kneer K; Schmid JS; Grigoleit GU; Hofmann S; Beer AJ; Bunjes D; Knop S; Buck AK; Einsele H; Lapa C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1694-1704. PubMed ID: 29610955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of
    Ling T; Zhang L; Peng R; Yue C; Huang L
    Front Immunol; 2022; 13():1014063. PubMed ID: 36466905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma: A systematic review and meta-analysis.
    Zhu D; Wang L; Zhang H; Chen J; Wang Y; Byanju S; Liao M
    Medicine (Baltimore); 2017 Aug; 96(33):e7813. PubMed ID: 28816978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Evaluation of Magnetic Resonance Imaging and [
    Moreau P; Attal M; Caillot D; Macro M; Karlin L; Garderet L; Facon T; Benboubker L; Escoffre-Barbe M; Stoppa AM; Laribi K; Hulin C; Perrot A; Marit G; Eveillard JR; Caillon F; Bodet-Milin C; Pegourie B; Dorvaux V; Chaleteix C; Anderson K; Richardson P; Munshi NC; Avet-Loiseau H; Gaultier A; Nguyen JM; Dupas B; Frampas E; Kraeber-Bodere F
    J Clin Oncol; 2017 Sep; 35(25):2911-2918. PubMed ID: 28686535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of an
    Dong X; Wang R; Ying X; Xu J; Yan J; Xu P; Peng Y; Chen B
    Hematology; 2024 Dec; 29(1):2329029. PubMed ID: 38488443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma.
    Nanni C; Zamagni E
    PET Clin; 2019 Jul; 14(3):383-389. PubMed ID: 31084777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy?
    Zukovs R; Antke C; Mamlins E; Sawicki LM; Mohring A; Lopez Y Niedenhoff D; Boquoi A; Kondakci M; Antoch G; Müller HW; Fenk R; Haas R
    BMC Med Imaging; 2022 Apr; 22(1):63. PubMed ID: 35379187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment
    Abe Y; Narita K; Kobayashi H; Kitadate A; Miura D; Takeuchi M; O'uchi E; O'uchi T; Matsue K
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1325-1333. PubMed ID: 30687892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on
    Liu X; Xiang K; Geng GY; Wang SC; Ni M; Zhang YF; Pan HF; Lv WF
    Contrast Media Mol Imaging; 2022; 2022():2586245. PubMed ID: 35173559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with
    Risør LM; Clausen MM; Ujmajuridze Z; Farhadi M; Andersen KF; Loft A; Friborg J; Kjaer A
    J Nucl Med; 2022 Aug; 63(8):1169-1176. PubMed ID: 34857658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility and prognostic value of
    Aljama MA; Sidiqi MH; Buadi FK; Lacy MQ; Gertz MA; Dispenzieri A; Dingli D; Muchtar E; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Warsame RM; Kourelis T; Hwa YL; Kapoor P; Kyle RA; Leung N; Go RS; Rajkumar SV; Kumar SK
    Am J Hematol; 2018 Dec; 93(12):1518-1523. PubMed ID: 30194770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of (18)F-FDG PET/CT in newly diagnosed multiple myeloma patients].
    Wang CY; Wu L; Sun CT; Wang X; Xia B; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(4):301-306. PubMed ID: 30669718
    [No Abstract]   [Full Text] [Related]  

  • 20. A prognostication system based on clinical parameters and [
    Li J; Zhang X; Qin C; Sun X; Xu X; Cao G; Gai Y; Sun C; Hu Y; Lan X
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1665-1670. PubMed ID: 36576511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.